← Back to Clinical Trials
Recruiting NCT05838404

NCT05838404 M-O-M-S on the Bayou: Implementation of an Intervention for Mental Health in Pregnancy

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT05838404
Status Recruiting
Phase
Sponsor Tulane University
Condition Anxiety
Study Type INTERVENTIONAL
Enrollment 240 participants
Start Date 2023-11-01
Primary Completion 2025-11-30

Eligibility & Interventions

Sex Female only
Min Age 18 Years
Max Age N/A
Study Type INTERVENTIONAL
All Conditions
Interventions
M-O-M-S on the Bayou

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 240 participants in total. It began in 2023-11-01 with a primary completion date of 2025-11-30.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

Disasters have negative effects in the short term (physical trauma, adverse environmental exposures, and unstable housing) and the long term (relocation, changes in family functioning, and negative economic effects), which interact with social determinants to worsen health among the most vulnerable women, infants, and communities. Trauma and severe stress are directly linked to pregnancy complications, and raise blood pressure during pregnancy, alter stress hormones, and increase vulnerability to infection, all of which predispose to reduced fetal growth and preterm birth. Disasters also worsen mental health, and depression during pregnancy and postpartum, for instance, is associated with worse physical health during pregnancy, maternal impairment, poorer quality parenting, negative child behavior, and poorer infant cognitive development.The goal of this intervention is to improve mental health in pregnant women living in a disaster-affected region. The main questions this intervention aims to answer are: * Assess the implementation outcomes (acceptability, adaptation, adoption, feasibility, fidelity, and sustainability) of a pilot intervention in a disaster recovery environment. * Assess the effectiveness of the M-O-M-S pilot intervention in a disaster recovery environment. The study will recruit pregnant women in areas that have experienced a natural disaster. Women will be recruited in early pregnancy and attend a series of classes on the cognitive and relationship changes of pregnancy and motherhood, and mental preparation for labor, led by a "mentor," a mother who has experienced pregnancy, labor, and motherhood.

Eligibility Criteria

Inclusion Criteria: * Pregnant * Below 20 weeks' gestation * Enrolled in prenatal care Exclusion Criteria: * Not pregnant * Under age 18 * Does not speak English or Spanish * Does not plan to carry to term * Does not plan to remain in the study area through pregnancy * Fetal defects likely to lead to death or extensive hospitalization postpartum

Contact & Investigator

Central Contact

Emily Harville, PhD

✉ eharvill@tulane.edu

📞 504-988-7327

Frequently Asked Questions

Who can join the NCT05838404 clinical trial?

This trial is open to female participants only, aged 18 Years or older, studying Anxiety. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT05838404 currently recruiting?

Yes, NCT05838404 is actively recruiting participants. Contact the research team at eharvill@tulane.edu for enrollment information.

Where is the NCT05838404 trial being conducted?

This trial is being conducted at New Orleans, United States.

Who is sponsoring the NCT05838404 clinical trial?

NCT05838404 is sponsored by Tulane University. The trial plans to enroll 240 participants.

Related Trials

Related Intelligence Guides

In-depth guides covering this condition's trials, eligibility, and what to expect.

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology